Working at Novartis | Glassdoor.co.uk

Novartis Overview

Basel (Switzerland)
10000+ employees
1996
Company - Public (NVS)
Biotech & Pharmaceutical
£10+ billion (GBP) per year
At Novartis, we use science-based innovation to address some of society’s most challenging healthcare issues. We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible.

Channel ... Read more

Mission: Our mission is to discover new ways to improve and extend people`s lives. Our vision is to be a trusted leader in changing the practice of medicine. www.novartis.com

Company Updates

  • 4 weeks , 4 stories. Pride month. Isobel shares her candid “Past, present and proud” story.
    http://glassdoor.com/slink.htm?key=vMFUQ

  • 4 weeks , 4 stories. Pride month. Susan shares her “Past, present and proud” story. http://glassdoor.com/slink.htm?key=vMBrP

See AllSee All

Novartis – Why Work For Us?


750 million!

That’s how many lives our products touch. 200 projects currently in clinical development. 16 major approvals last year alone. These are achievements we’re incredibly proud of, but in this world of digital and technological transformation, we must also ask ourselves this: how can we continue to improve and extend even more people’s lives?  

 


Novartis focuses on innovative patent-protected medicines, generics and eye care products – segments where we have global reach and strong relations with our customers. Research and development (R&D) sits at the core of our business and central to our strategy. Our global organizations for manufacturing, business services and other functions help increase efficiency and promote excellence.

Our Divisions

Innovative Medicines:

The Innovative Medicines Division has two business units:

Novartis Pharmaceuticals focuses on patented treatments in the areas of ophthalmology; immunology, hepatology and dermatology; neuroscience; respiratory; and cardio-metabolic.

Novartis Oncology focuses on patented treatments for a variety of cancers and rare diseases.

Sandoz offers patients and healthcare professionals high-quality, affordable generics and biosimilars.

Functional organizations with a global reach:

Novartis Institutes for BioMedical Research (NIBR) is the innovation engine of Novartis. NIBR focuses on discovering new drugs that can change the practice of medicine.

Global Drug Development (GDD) organization oversees the development of new medicines discovered by our researchers and partners.

Novartis Technical Operations (NTO) handles manufacturing of innovative medicines and Sandoz products. NTO helps us optimize resource allocation and capacity planning across our production sites.

Novartis Business Services (NBS) consolidates support services across our organization, helping drive efficiency, simplification, standardization and quality.

Corporate Functions support the enterprise in specific areas of expertise, including finance, human resources, legal and communications.

Medical innovation helps address the UK’s healthcare challenges

We live in a golden age for medical innovation. By constantly questioning the status quo, we continue to push boundaries and drive science forwards. Novartis researchers are doing just that. We are working on exciting new innovations which just a few years ago were the stuff of science fiction.

For example, people’s immune systems are being reprogrammed to battle cancer, and genetic defects that cause disease can now be corrected. Our contributions to medical science are helping to tackle untamed diseases and drive dramatic improvements in healthcare within the UK.


These trends have led to major healthcare challenges in the UK. There is an increased demand for care, the National Health Service (NHS) is under pressure and Government needs to seek new ways to stem rising costs. As a result, patients in the UK are waiting longer than many of their European counterparts to access the vital medicines they need.


Our research offers hope to patients, healthcare professionals and the NHS. We have a duty to patients and are committed to ensuring that our knowledge and expertise is harnessed to pursue revolutionary new therapies. Our rich pipeline has both breadth and depth, and includes cancer, heart failure, immune system disorders, neuroscience and sight loss, among many others.

We recognise the excellence of the scientific and medical community in the UK. Our R&D activities are enhanced by working with world-renowned UK healthcare professionals and NHS trusts. Conducting our clinical trials locally can lead to improved quality of care for many patients in the UK.

Access & Corporate Responsibility in the UK:

We are proud of our ongoing partnership with the NHS. We invest more in joint working projects with the NHS in the UK than the industry average. Ground-breaking advances in medicine are only meaningful if they reach the people who need them. But access to healthcare is complex and the NHS faces many challenges in managing the growing and aging population Novartis has a long history of collaboration with the NHS.

By pooling resources and expertise from both sides, we work closely with the NHS and Government to find access solutions and transform the care that patients receive. Since 2011, we have been involved in over 100 joint working initiatives in the UK, and are committed to many more. We want to see the NHS be a sustainable health service not just for today, but for future generations to come.

Tackling infectious diseases, chronic conditions and strengthening healthcare systems remain key focus areas for improving health in low-income countries. The UK continues to be a leading donor and contributor in the fight against global diseases and we are also proud to be a part of it.


Our Environment

We are committed to minimising our environmental impact and becoming a ‘greener’ company. ‘Vision 2030’ is a set of targets, which we have defined to help reduce our environmental impact and increase sustainability in the UK by 2030.

Energy and greenhouse gas emissions - we have set targets for reducing global  greenhouse gas emissions by 30% by 2020 and by 50% by 2030, compared to 2010.

Waste - we strive to use materials effectively to prevent waste in the first place. Our target is to reduce non-recycled operational waste relative to production by 30% by 2030.

Water and micro-pollutants - by 2020, our target for site effluents (liquid waste) is 10-fold below the concentration that could be harmful to the environment.


Global Access & Corporate Responsibility:

Colleague in Ghana



Corporate responsibility is endorsed and ingrained at the highest level of Novartis and is central to how we run our business.

We are inspired by helping patients and the communities where we live and work. This not only includes our day-to-day efforts as we develop and make available innovative medicines, but also how we give back through volunteering, charitable giving, and patient assistance programs.

Expanding Access to Healthcare: Developing new and innovative ways to reach people in lower-income countries is one of our top priorities. To expand access to healthcare, we pursue a variety of approaches.

Doing Business Responsibly: We recognize that achieving our business goals requires that we operate with high integrity, transparency and environmental sustainability.

Corporate Responsibility Report: Novartis has a strong history of corporate responsibility activities, and transparent reporting is a central part of our commitment.

750 million!

That’s how many lives our products touched in 2018. 200 projects currently in clinical development. 16 major approvals last year alone. These are achievements we’re incredibly proud of, but in this world of digital and technological transformation, we must also ask ourselves this: how can we continue to improve and extend even more people’s lives?  


We believe the answers are found when curious, courageous and collaborative people like you are brought together in an inspiring environment. Where you’re given the opportunity to explore the power and potential of data and digital. Where you’re empowered to risk failure by taking smart risks. Where you’re encouraged to share new ideas that can open up new ways of making things happen. And where you’re surrounded by teams who are equally determined to transform lives by tackling the world’s toughest medical challenges.

 

Our people and culture

Our people are in the grip of a long and arduous campaign against the invisible enemy of disease, often hard to find and hard to fight. Our researchers often fail. We recognise that failure brings us closer to success. And we’ll endure a lot more failure if success means solving some of humanity’s most difficult problems.

We fight for life.

We are united by a shared purpose of putting patients at the heart of everything we do. That’s why we come to work every day. We embrace diversity and inclusion. Diversity enhances our ability to see the world through the eyes of our patients, and enables us to deliver insight-driven, creative solutions to meet their needs.

Our people make our business. They discover, develop and facilitate access to our medicines. We have created a working environment that enables our associates to truly invest in their careers by giving them the support and flexibility they need. We have a range of talent programmes, development schemes and wellbeing initiatives to ensure a healthy personal and work life balance.

Careers

Novartis is committed to the UK life sciences industry and employs over 1,500 people across four sites in the UK. We have many types of employment opportunities spanning from manufacturing and sales and marketing, through to regulatory and medical roles. We have opportunities for people across different stages of their careers, from undergraduate placements and apprenticeships, through to new graduates and those more experienced in the industry.

Meet some of the team: https://www.novartis.co.uk/careers/working-novartis/meet-our-people


Our differences make us powerful

While our diverse workforce brings different people and perspectives together, inclusion is making the mix work. It is about creating an atmosphere and an environment where each of us feels valued, respected and heard.

Novartis Reviews

3.7
StarStarStarStarStar
Rating TrendsRating Trends
Recommend to a friend
Approve of CEO
Novartis CEO Vas Narasimhan
Vas Narasimhan
304 Ratings
  • Featured Review

    Helpful (1)

    "Novartis Pharmaceuticals"

    StarStarStarStarStar
    • Work/Life Balance
    • Culture & Values
    • Career Opportunities
    • Comp & Benefits
    • Senior Management
    Current Employee - Sales Representative
    Current Employee - Sales Representative
    Recommends
    Positive Outlook
    Approves of CEO

    I have been working at Novartis full-time (More than 5 years)

    Pros

    Great company to work for. Lots of opportunities to grow and develop

    Cons

    No cons to report. Have had a great experience

See All 3,315 Reviews

Novartis Photos

Novartis photo of: Frank Gehry Building - Basel Campus
Novartis photo of: Community Partnership Day 2018
Novartis photo of: Community Partnership Day 2018
Novartis photo of: Community Partnership Day
Novartis photo of: Getting into the World Cup spirit
Novartis photo of: Community Partnership Day
See All PhotosSee All

Novartis Interviews

Experience

Experience
65%
20%
15%

Getting an Interview

Getting an Interview
41%
17%
14%
10
8
6
4

Difficulty

3.0
Average

Difficulty

Hard
Average
Easy
  1.  

    Intern Interview

    Anonymous Employee
    Accepted Offer
    Positive Experience
    Average Interview

    Application

    I applied online. The process took 4+ weeks. I interviewed at Novartis.

    Interview

    Telephone, then face to face assessment centre style with a presentation and written exercise, as well as a competency based interview. Everyone was friendly and it felt relaxed. It was good to meet other candidates too.

    Interview Questions

    • What have you learned from working in a team.   1 Answer
See All 677 Interviews

Novartis Awards & Accolades

  • India’s Best Companies to work for 2016, Great Places to Work, 2016
  • TOP 100 Employers Ranking - voted the most attractive Swiss employer in the field of natural sciences., Universum, 2018
  • Corporate Reputation of Pharma - in the Top Three, PatientView, 2016
  • Top 10 Pipelines, MedAdNews, 2017
  • Top 100 Global Innovators, Clarivate Analytics (formerly the IP & Science division of Thomson Reuters)., 2016
See More

Work at Novartis? Share Your Experiences

Novartis
  • Star
  • Star
  • Star
  • Star
  • Star
 
Click to Rate
or